Bright Minds Biosciences (DRUG) said Friday it launched a private placement of common shares at a price of $21.70 per share.
The biotechnology company also said it has a right to issue pre-funded warrants at $21.70 apiece, with each warrant being exercisable into one pre-funded warrant share for $0.001.
Bright Minds Biosciences said it expects aggregate gross proceeds of up to $35 million, which will be used for research and development related of drug development programs, as well as general capital purposes.
Shares of the company were up 33% in recent Friday premarket activity.
Price: 28.89, Change: +7.19, Percent Change: +33.13
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。